Pacira BioSciences' Operating Income rose 104.56% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.6 million, marking a year-over-year increase of 164.02%. This contributed to the annual value of -$73.4 million for FY2024, which is 183.69% down from last year.
Per Pacira BioSciences' latest filing, its Operating Income stood at $6.4 million for Q3 2025, which was down 25.14% from $8.5 million recorded in Q2 2025.
Pacira BioSciences' Operating Income's 5-year high stood at $39.9 million during Q2 2023, with a 5-year trough of -$139.5 million in Q3 2024.
In the last 3 years, Pacira BioSciences' Operating Income had a median value of $13.2 million in 2024 and averaged $2.8 million.
In the last 5 years, Pacira BioSciences' Operating Income soared by 587.52% in 2021 and then slumped by 887.35% in 2024.
Over the past 5 years, Pacira BioSciences' Operating Income (Quarterly) stood at $4.2 million in 2021, then plummeted by 334.93% to -$9.9 million in 2022, then skyrocketed by 435.27% to $33.2 million in 2023, then declined by 25.52% to $24.7 million in 2024, then surged by 104.56% to $6.4 million in 2025.
Its last three reported values are $6.4 million in Q3 2025, $8.5 million for Q2 2025, and $2.0 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value